×

Landec Sets September 2014 Investor Conference Schedule

MENLO PARK, Calif., Sept. 2, 2014 (GLOBE NEWSWIRE) -- Landec Corporation (Nasdaq:LNDC), a leading developer and marketer of innovative products for healthy living applications in the food and biomedical markets, plans to participate in three financial conferences in September 2014.

Management will present as well as hold one-on-one meetings with institutional investors at the respective events. They will discuss the company's fiscal 2014 results, which were driven by strong sales of its new Eat Smart® superfood products and Lifecore products, as well as provide the company's outlook for growth.

Liolios Group 3rd Annual Gateway Conference
Presentation: Thursday, September 4
Where: The Palace Hotel, San Francisco
Executive: Greg Skinner, CFO
Imperial Capital 8th Annual Global Opportunities Conference
Presentation: Thursday, September 18
Where: Waldorf Astoria, New York
Executive: Greg Skinner, CFO
Wedbush California Dreamin' Consumer Conference: "The NY Edition"
Presentation: Tuesday, September 23
Where: Le Parker Meridien, New York
Executive: Molly Hemmeter, COO

For additional information or to schedule a one-on-one meeting with Landec management, please contact Matt Glover or Michael Koehler at Liolios Group, or your representative at Imperial Capital and Wedbush Securities.

About Landec Corporation

Landec Corporation is a company that leverages its proprietary polymer technologies, application development and innovation capabilities to develop and commercialize new products in food and biomaterials markets. Landec's subsidiary, Apio, has become the leader in US fresh-cut specialty packaged vegetables sold in North America based on combining Landec's proprietary food packaging technology and the strength of two major national brands, Eat Smart® and GreenLine®, with the capabilities of large scale processing and national distribution. Lifecore Biomedical, a subsidiary of Landec, is a premium supplier of hyaluronan-based materials and medical products to ophthalmic, orthopedic and veterinary markets worldwide. In addition, Lifecore Biomedical provides specialized aseptic fill and finish services in a cGMP validated manufacturing facility for supplying commercial, clinical and pre-clinical products. For more information about the Company, visit Landec's website at www.landec.com.

CONTACT: At the Company: Gregory S. Skinner Vice President Finance and CFO (650) 261-3677 Investor Relations: Matt Glover or Michael Koehler 949-574-3860 LNDC@liolios.com

Source:Landec Corporation